Pmv Pharma Rg

Precision oncology firm PMV Pharma develops orally available small‑molecule therapies that correct p53 mutations, notably Y220C, aiming to become a leader in tumor‑agnostic treatments. Headquarters: Princeton, USA.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 47
HQ: Princeton

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
PMVP	Pmv Pharma Rg Cap: 0.1B	EQUITY	NMS	USD	US69353Y1038	Active	📈